Rostami R, Aghasi MR, Mohammadi A, Nourooz-Zadeh J (2013) Enhanced oxidative stress in Hashimotos thyroiditis: inter-relationships to biomarkers of thyroid function
Originally developed by Metabolic Pharmaceuticals (Australia) in the early 2000s, it has been investigated extensively in metabolic and lipolysis research as a fragment that retains hGHs fat-mobilising activity without its insulin-like or growth-promoting effects
PMID: 139 DongHXiaYJinSXueCWangYHuRet al
Molecular Mechanistic Profile Mechanistically, BPC157 has been associated with: Strong angiogenic activity: stimulation of VEGF/VEGFR2 signaling, increased endothelial cell proliferation, and enhanced vascular running (growth of new vessels toward injured areas)
Typical research applications include: Investigation of NNMT inhibition and its role in metabolic regulation
10.21037/tlcr-21-303 270 ZhangW.JiangB.LiuY.XuL.WanM